Immunovant Chief Medical Officer Michael Geffner Steps Down-February 2024-www.financetom.com

Immunovant Chief Medical Officer Michael Geffner Steps Down

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Immunovant Chief Medical Officer Michael Geffner Steps Down

Nov 21, 2025 6:24 AM

09:02 AM EST, 11/21/2025 (MT Newswires) -- Immunovant ( IMVT ) said in a regulatory filing Friday that its Chief Medical Officer Michael Geffner has stepped down from his role, effective immediately.

Geffner will offer certain consulting services to the company through April 30, Immunovant ( IMVT ) said in its 8-K filing with the US Securities and Exchange Commission.

Previous page： --H&R Block Keeps Quarterly Dividend at $0.32 a Share, Payable July 3 to Shareholders of Record as of June 5 Next page： Jack Henry lifts annual profit forecast on robust demand for fintech products

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--H&R Block Keeps Quarterly Dividend at $0.32 a Share, Payable July 3 to Shareholders of Record as of June 5

May 7, 2024

05:13 PM EDT, 05/07/2024 (MT Newswires) -- Price: 47.88, Change: -1.43, Percent Change: -2.90 ...

Jack Henry lifts annual profit forecast on robust demand for fintech products

May 7, 2024

May 7 (Reuters) - Fintech firm Jack Henry & Associates ( JKHY ) on Tuesday raised its full-year profit forecast and reported a near 7% rise in third-quarter profit, helped by a strong performance in its processing as well as services and support segments. Financial technology and payments companies' products, which include lending, consulting, payments and digital banking, have seen...

Corvus Pharmaceuticals Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing

May 7, 2024

05:12 PM EDT, 05/07/2024 (MT Newswires) -- Richard A Miller, Director, President and CEO, on May 06, 2024, executed a purchase for 577,634 shares in Corvus Pharmaceuticals ( CRVS ) for $1,000,000. Following the Form 4 filing with the SEC, Miller has control over a total of 2,067,753 shares of the company, with 577,634 shares held directly and 1,490,119 controlled...

M&t Bank Insider Sold Shares Worth $495,125, According to a Recent SEC Filing

May 7, 2024

05:13 PM EDT, 05/07/2024 (MT Newswires) -- Doris P. Meister, Senior Executive Vice President, on May 03, 2024, sold 3,362 shares in M&t Bank ( MTB ) for $495,125. SEC Filing: https://www.sec.gov/Archives/edgar/data/36270/000120919124005562/xslF345X03/doc4.xml ...